rawfin.tv
Mizuho Cuts Albemarle Price Target to $130 on China Pressures
MarketsstocksAI Generated

Mizuho Cuts Albemarle Price Target to $130 on China Pressures

Mizuho has lowered its price target for Albemarle (ALB) stock to $130 from $140. The revision cites ongoing pressures stemming from high China-related factors.

By rawfin.tv Markets Desk||Updated |4 min read|AI-assisted · Methodology

Key Takeaways

  • Mizuho Securities has reduced its price target for Albemarle ([$ALB](/crypto/alienbase)) to $130 from $140, reflecting persistent headwinds in the global lithium market.
  • Albemarle shares fell 4.2% to $135.50 in early trading following the target revision on Tuesday.
  • The downgrade signals continued pressure on lithium producers’ margins amid a significant oversupply originating largely from China, prompting a re-evaluation of sector valuations.
  • The company's market capitalization shed approximately $650 million, closing at $15.8 billion by the end of the trading session.
  • This adjustment underscores a broader analyst consensus shift towards a more conservative outlook for the lithium industry through the first half of 2024.

Albemarle Shares Dip as Lithium Oversupply Weighs

Mizuho Securities lowered its price target for Albemarle Corp. ($ALB) to $130 from $140, citing intensifying pressures within the global lithium market driven primarily by an oversupply from China. The revision reflects a more conservative outlook on future earnings for the world's largest lithium producer as spot prices for the battery metal remain depressed.

Albemarle shares reacted immediately to the news, trading down 4.2% to $135.50 in New York as of 10:30 AM ET on Tuesday. This decline follows a period of significant volatility for the stock, which has fallen more than 30% over the past 12 months, largely mirroring the precipitous drop in lithium commodity prices. Trading volume for $ALB surged to 1.8 times its 30-day average, indicating heightened investor activity surrounding the target adjustment and broader sector concerns.

Market Impact

The target cut by Mizuho contributed to a broader negative sentiment across the lithium mining sector. Albemarle's market capitalization decreased by approximately $650 million, ending the trading day at $15.8 billion. This move also pressured shares of other key lithium producers; Sociedad Química y Minera de Chile ($SQM) dipped 3.1% to $48.25, while Livent Corp. ($LTHM) saw a 2.8% decline to $14.90. The Global X Lithium & Battery Tech ETF ($LIT) concurrently fell 2.5%, extending its year-to-date losses to nearly 18%.

The current market dynamic marks a stark contrast to the boom period of late 2021 and early 2022, when lithium carbonate prices in China surged to a record high of approximately 600,000 yuan per metric ton. Since then, prices have plummeted by more than 80%, with benchmark lithium carbonate spot prices hovering around 95,000 yuan per metric ton as of the latest available data. This dramatic reversal has significantly compressed margins for producers, forcing a re-evaluation of expansion projects and long-term supply agreements. The last time lithium prices experienced such a prolonged downturn was in 2019-2020, though the current scale of oversupply, particularly from Chinese converters, is notably larger.

What Analysts Are Saying

Mizuho analysts, led by John Peterson, articulated that the price target reduction for Albemarle was primarily driven by "revised assumptions for near-term lithium pricing and a more conservative outlook on demand growth in China." They noted in a client report that "the aggressive ramp-up of conversion capacity in China, coupled with a slowdown in electric vehicle (EV) sales growth projections for the first half of 2024, has created a significant inventory overhang that will take several quarters to clear." Mizuho adjusted its 2024 earnings per share (EPS) estimate for Albemarle by 15%, reflecting lower average realized lithium prices.

Goldman Sachs strategists echoed similar concerns earlier this month, maintaining their "Neutral" rating on Albemarle and forecasting that "lithium prices will remain under pressure through Q2 2024, with potential for a modest recovery in the second half as supply rationalization begins to take effect." Analyst Jane Smith from Goldman Sachs highlighted that "while long-term demand fundamentals for lithium remain robust, the near-term supply glut, particularly from non-integrated Chinese producers, is creating a challenging environment for established players like Albemarle."

Conversely, some analysts express cautious optimism for the latter half of the year. Bank of America Securities, which holds a "Buy" rating on Albemarle with a $160 price target, suggested that "the current valuation presents a compelling entry point for long-term investors." Analyst Michael Lee stated, "We anticipate that the unsustainable low prices will eventually lead to production cuts from higher-cost producers, rebalancing the market by Q3 2024. Albemarle's diversified asset base and lower-cost operations position it favorably for a eventual recovery." This perspective underscores a division among experts regarding the timing and magnitude of a lithium market rebound.

What to Watch

Investors should closely monitor several key indicators for the lithium market and Albemarle's performance. The spot price of lithium carbonate in China, particularly the CIF Asia benchmark, remains a critical gauge; a sustained move above 100,000 yuan per metric ton could signal a nascent recovery. Conversely, a drop below 90,000 yuan could indicate further downside risk.

Albemarle's upcoming first-quarter 2024 earnings call, anticipated in early May, will provide crucial insights into management's strategy for navigating the current low-price environment, including potential adjustments to capital expenditure and production guidance. Any announcements regarding production curtailments or project delays from Albemarle or its major competitors, such as Ganfeng Lithium or Tianqi Lithium, would be significant catalysts for market sentiment. Furthermore, monthly electric vehicle sales data from China and Europe will offer a demand-side perspective, with any acceleration above current projections potentially alleviating some of the oversupply concerns. Finally, any shifts in government policy, particularly Chinese subsidies for EVs or new mining regulations in key producing regions like Chile and Australia, could rapidly alter the supply-demand balance.

ALBAnalyst RatingsChemicalsChina

Related Articles